Sign in

CIK 0001711279

  • Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
821080209
Phone
+1 412-586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 4 Shares withheld for taxes President, R&D gave up 9,256 shares (to pay taxes)
  2. 4 Shares withheld for taxes President and CEO gave up 9,256 shares (to pay taxes)
  3. 4 Shares withheld for taxes President, R&D gave up 2,353 shares (to pay taxes)
  4. 4 Shares withheld for taxes President and CEO gave up 3,791 shares (to pay taxes)
  5. 4 Planned sale Chief Accounting Officer sold 8,087 shares at an average $136.91 ($1,107,180)
  6. 4 Planned sale Chief Accounting Officer sold 2,500 shares at $130.00 ($325,000)
  7. 4 Planned sale President, R&D sold 50,000 shares at an average $105.67 ($5,283,291)
  8. 4 Planned sale President and CEO sold 50,000 shares at an average $105.67 ($5,283,291)
  9. 4 Planned sale President, R&D sold 50,000 shares at an average $127.23 ($6,361,680)
  10. 4 Planned sale President and CEO sold 50,000 shares at an average $127.23 ($6,361,680)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Director sold 50,000 shares at an average $128.36 ($6,418,077)
  18. 4 Planned sale Chief Commercial Officer sold 12,500 shares at an average $128.61 ($1,607,635)
  19. 4 Open-market sale President, R&D sold 50,000 shares at an average $116.20 ($5,809,889)
  20. 4 Open-market sale President and CEO sold 50,000 shares at an average $116.20 ($5,809,889)

Page 4 of 10 · 186 filings